Cargando…
Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406513/ https://www.ncbi.nlm.nih.gov/pubmed/37554172 http://dx.doi.org/10.3389/fonc.2023.1226974 |
| _version_ | 1785085759886196736 |
|---|---|
| author | Amoozgar, Zohreh Jaymand, Mehdi Jahanban-Esfahlan, Rana |
| author_facet | Amoozgar, Zohreh Jaymand, Mehdi Jahanban-Esfahlan, Rana |
| author_sort | Amoozgar, Zohreh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10406513 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104065132023-08-08 Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients Amoozgar, Zohreh Jaymand, Mehdi Jahanban-Esfahlan, Rana Front Oncol Oncology Frontiers Media S.A. 2023-07-24 /pmc/articles/PMC10406513/ /pubmed/37554172 http://dx.doi.org/10.3389/fonc.2023.1226974 Text en Copyright © 2023 Amoozgar, Jaymand and Jahanban-Esfahlan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Amoozgar, Zohreh Jaymand, Mehdi Jahanban-Esfahlan, Rana Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients |
| title | Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients |
| title_full | Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients |
| title_fullStr | Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients |
| title_full_unstemmed | Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients |
| title_short | Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients |
| title_sort | editorial: circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406513/ https://www.ncbi.nlm.nih.gov/pubmed/37554172 http://dx.doi.org/10.3389/fonc.2023.1226974 |
| work_keys_str_mv | AT amoozgarzohreh editorialcirculatingmolecularbiomarkersnextgenerationtoolsformonitoringminimalresidualdiseaseincancerpatients AT jaymandmehdi editorialcirculatingmolecularbiomarkersnextgenerationtoolsformonitoringminimalresidualdiseaseincancerpatients AT jahanbanesfahlanrana editorialcirculatingmolecularbiomarkersnextgenerationtoolsformonitoringminimalresidualdiseaseincancerpatients |